METASTATIC ADENOCARCINOMA OF THE PANCREAS
Clinical trials for METASTATIC ADENOCARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOCARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for METASTATIC ADENOCARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of four chemo drugs shows promise for tough pancreatic cancer
Disease control CompletedThis phase 2 trial tested a combination of four chemotherapy drugs—irinotecan liposome, oxaliplatin, 5-fluorouracil, and levoleucovorin—in 41 Japanese adults with metastatic pancreatic cancer who had not received prior treatment. The goal was to see how well the drugs shrank tumo…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New liposomal chemo cocktail takes on pancreatic cancer
Disease control CompletedThis Phase 3 trial tested a new combination of chemotherapy drugs—irinotecan liposome, oxaliplatin, 5-fluorouracil, and leucovorin—against the standard treatment (nab-paclitaxel plus gemcitabine) in 770 people with metastatic pancreatic cancer who had not received prior chemother…
Matched conditions: METASTATIC ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC